Tapewire

Nasdaq · USD

RGEN

REPLIGEN CORP

Export transactions ↓
Tapewire entity
486
SEC CIK
0000730272
Parsed reports
388

Last 12 months

Inside the activity.

0 purchase rows · 25 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025014
Dec 202501
Jan 202600
Feb 202600
Mar 202600
Apr 202601
May 202600
Jun 202601
Jul 202601
Aug 202601
Sep 202604
Oct 202602

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 28, 2019 Filed Mar 4, 2019 23:52 UTC
KURIYEL RALFSenior VP, R&D
GrantStock Option (Right to Buy) · Derivative 4,042 $0.00 Strike: $59.52 $0.00
Disclosure

SEC source: 0000899243-19-005883 · doc4.xml · derivative · entry 3

KURIYEL RALF · CIK 0001733143 · Senior VP, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,042

Underlying: Common Stock · 4,042 shares

Expires 2029-02-28

F3 · derivative.exercise_date: One third of the stock options will vest and become exercisable annually on February 28, 2020, February 28, 2021 and February 28, 2022.

Read SEC document
February 28, 2019 Filed Mar 4, 2019 23:52 UTC
KURIYEL RALFSenior VP, R&D
SaleCommon Stock 185 $59.16 $10,944.60
Disclosure

SEC source: 0000899243-19-005883 · doc4.xml · nonDerivative · entry 2

KURIYEL RALF · CIK 0001733143 · Senior VP, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,343

F2 · kind: Sale of 185 shares in the open market to cover tax liability resulting from the release of restricted stock units.

Read SEC document
February 28, 2019 Filed Mar 4, 2019 23:52 UTC
KURIYEL RALFSenior VP, R&D
GrantCommon Stock 4,234 $0.00 $0.00
Disclosure

SEC source: 0000899243-19-005883 · doc4.xml · nonDerivative · entry 1

KURIYEL RALF · CIK 0001733143 · Senior VP, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,528

F1 · shares: Mr. Kuriyel was awarded 4,234 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only be delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

Read SEC document
February 28, 2019 Filed Jun 11, 2019 23:03 UTC Amendment
KURIYEL RALFSenior VP, R&D
GrantStock Option (Right to Buy) · Derivative 4,061 $0.00 Strike: $59.52 $0.00
Disclosure

SEC source: 0000899243-19-016508 · doc4a.xml · derivative · entry 1

KURIYEL RALF · CIK 0001733143 · Senior VP, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,061

Underlying: Common Stock · 4,061 shares

Expires 2029-02-28

F1 · derivative.exercise_date: One third of the stock options will vest and become exercisable annually on February 28, 2020, February 28, 2021 and February 28, 2022.

Read SEC document
February 28, 2019 Filed Jun 11, 2019 23:07 UTC Amendment
Snodgres JonChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 5,681 $0.00 Strike: $59.52 $0.00
Disclosure

SEC source: 0000899243-19-016513 · doc4a.xml · derivative · entry 1

Snodgres Jon · CIK 0001613498 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,681

Underlying: Common Stock · 5,681 shares

Expires 2029-02-28

F1 · derivative.exercise_date: One third of the stock options will vest and become exercisable annually on February 28, 2020, February 28, 2021 and February 28, 2022.

Read SEC document
February 28, 2019 Filed Jun 11, 2019 22:59 UTC Amendment
Hunt AnthonyDirector · Chief Executive Officer
GrantStock Option (Right to Buy) · Derivative 21,756 $0.00 Strike: $59.52 $0.00
Disclosure

SEC source: 0000899243-19-016500 · doc4a.xml · derivative · entry 1

Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,756

Underlying: Common Stock · 21,756 shares

Expires 2019-02-28

F1 · derivative.exercise_date: One third of the stock options will vest and become exercisable annually on February 28, 2020, February 28, 2021 and February 28, 2022

Read SEC document
December 18, 2018 Filed Dec 20, 2018 21:22 UTC
KURIYEL RALFSenior VP, R&D
SaleCommon Stock 311 $54.44 $16,930.84
Disclosure

SEC source: 0000899243-18-031479 · doc4.xml · nonDerivative · entry 1

KURIYEL RALF · CIK 0001733143 · Senior VP, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,294

F1 · shares: Sale of 311 shares in the open market valued at a price of $54.44 per share on December 18,2018 to cover tax liability resulting from the release of restricted stock units.

Read SEC document
November 26, 2018 Filed Nov 28, 2018 21:43 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 10,253 $0.00 Strike: $26.05 $0.00
Disclosure

SEC source: 0000899243-18-029744 · doc4.xml · derivative · entry 9

Snodgres Jon · CIK 0001613498 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,127

Underlying: Common Stock · 10,253 shares

Expires 2026-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: Shares vest and become exercisable as follows: 5,126 shares on 2/26/2017, 5,127 shares on 2/26/2018 and 5,127 shares on 2/26/2019.

Read SEC document
November 26, 2018 Filed Nov 28, 2018 21:43 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 6,055 $0.00 Strike: $32.40 $0.00
Disclosure

SEC source: 0000899243-18-029744 · doc4.xml · derivative · entry 8

Snodgres Jon · CIK 0001613498 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,110

Underlying: Common Stock · 6,055 shares

Expires 2027-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: 6,055 shares vest and become exercisable on each of the following dates: 2/23/2018, 2/23/2019 and 2/23/2020.

Read SEC document
November 26, 2018 Filed Nov 28, 2018 21:43 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 4,000 $0.00 Strike: $24.50 $0.00
Disclosure

SEC source: 0000899243-18-029744 · doc4.xml · derivative · entry 7

Snodgres Jon · CIK 0001613498 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,000

Underlying: Common Stock · 4,000 shares

Expires 2024-07-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: 2,000 shares vest and become exercisable on each of the following dates: 7/14/2015, 7/14/2016, 7/14/2017, 7/14/2018 and 7/14/2019.

Read SEC document
November 26, 2018 Filed Nov 28, 2018 21:43 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 11,445 $0.00 Strike: $26.20 $0.00
Disclosure

SEC source: 0000899243-18-029744 · doc4.xml · derivative · entry 6

Snodgres Jon · CIK 0001613498 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,445 shares

Expires 2025-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This option is currently exercisable.

Read SEC document
November 26, 2018 Filed Nov 28, 2018 21:43 UTC SaleCommon Stock 31,753 $63.49 $2,015,915.41
Disclosure

SEC source: 0000899243-18-029744 · doc4.xml · nonDerivative · entry 5

Snodgres Jon · CIK 0001613498 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,899

F1 · shares: Sale of common stock was effective pursuant to a 10(b)5-1 trading plan adopted on September 19, 2018.

F2 · price: $63.4874 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.18 to $64.71, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
November 26, 2018 Filed Nov 28, 2018 21:43 UTC Exercise / conversionCommon Stock 10,253 $26.05 $267,090.65
Disclosure

SEC source: 0000899243-18-029744 · doc4.xml · nonDerivative · entry 4

Snodgres Jon · CIK 0001613498 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,652

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 26, 2018 Filed Nov 28, 2018 21:43 UTC Exercise / conversionCommon Stock 6,055 $32.40 $196,182.00
Disclosure

SEC source: 0000899243-18-029744 · doc4.xml · nonDerivative · entry 3

Snodgres Jon · CIK 0001613498 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,399

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 26, 2018 Filed Nov 28, 2018 21:43 UTC Exercise / conversionCommon Stock 4,000 $24.50 $98,000.00
Disclosure

SEC source: 0000899243-18-029744 · doc4.xml · nonDerivative · entry 2

Snodgres Jon · CIK 0001613498 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,344

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 26, 2018 Filed Nov 28, 2018 21:43 UTC Exercise / conversionCommon Stock 11,445 $26.20 $299,859.00
Disclosure

SEC source: 0000899243-18-029744 · doc4.xml · nonDerivative · entry 1

Snodgres Jon · CIK 0001613498 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,344

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 05, 2018 Filed Nov 6, 2018 23:29 UTC SaleCommon Stock 1,763 $65.75 $115,920.42
Disclosure

SEC source: 0000899243-18-028342 · doc4.xml · nonDerivative · entry 1

RYAN THOMAS F JR · CIK 0001263366 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,225

Read SEC document
September 10, 2018 Filed Sep 12, 2018 20:15 UTC
Hunt AnthonyDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 11,873 $0.00 Strike: $16.55 $0.00
Disclosure

SEC source: 0000899243-18-024274 · doc4.xml · derivative · entry 3

Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,127

Underlying: Common Stock · 11,873 shares

Expires 2024-05-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 10,000 shares vest and become exercisable on each of the following dates: 5/05/2015, 5/05/2016, 5/05/2017, 5/05/2018 and 5/05/2019.

Read SEC document
September 10, 2018 Filed Sep 12, 2018 20:15 UTC
Hunt AnthonyDirector · Chief Executive Officer
SaleCommon Stock 27,566 $57.71 $1,590,809.05
Disclosure

SEC source: 0000899243-18-024274 · doc4.xml · nonDerivative · entry 2

Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 227,451

F1 · shares: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on November 17, 2017.

F2 · price: $57.7091 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.18 to $58.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
September 10, 2018 Filed Sep 12, 2018 20:15 UTC
Hunt AnthonyDirector · Chief Executive Officer
Exercise / conversionCommon Stock 11,873 $16.55 $196,498.15
Disclosure

SEC source: 0000899243-18-024274 · doc4.xml · nonDerivative · entry 1

Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 255,017

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 29, 2018 Filed Aug 31, 2018 20:15 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 1,992 $0.00 Strike: $41.19 $0.00
Disclosure

SEC source: 0000899243-18-023645 · doc4.xml · derivative · entry 5

BARTHELEMY NICOLAS · CIK 0001283576 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,992 shares

Expires 2025-05-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option is currently exercisable.

Read SEC document
August 29, 2018 Filed Aug 31, 2018 20:15 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 2,434 $0.00 Strike: $38.76 $0.00
Disclosure

SEC source: 0000899243-18-023645 · doc4.xml · derivative · entry 4

BARTHELEMY NICOLAS · CIK 0001283576 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,434 shares

Expires 2027-05-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option is currently exercisable.

Read SEC document
August 29, 2018 Filed Aug 31, 2018 20:15 UTC SaleCommon Stock 6,580 $54.44 $358,196.12
Disclosure

SEC source: 0000899243-18-023645 · doc4.xml · nonDerivative · entry 3

BARTHELEMY NICOLAS · CIK 0001283576 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,186

F1 · price: $54.4371 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.39 to $54.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 29, 2018 Filed Aug 31, 2018 20:15 UTC Exercise / conversionCommon Stock 1,992 $41.19 $82,050.48
Disclosure

SEC source: 0000899243-18-023645 · doc4.xml · nonDerivative · entry 2

BARTHELEMY NICOLAS · CIK 0001283576 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,766

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 29, 2018 Filed Aug 31, 2018 20:15 UTC Exercise / conversionCommon Stock 2,434 $38.76 $94,341.84
Disclosure

SEC source: 0000899243-18-023645 · doc4.xml · nonDerivative · entry 1

BARTHELEMY NICOLAS · CIK 0001283576 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,774

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 28, 2018 Filed Aug 29, 2018 20:15 UTC SaleCommon Stock 14,460 $52.79 $763,359.31
Disclosure

SEC source: 0000899243-18-023467 · doc4.xml · nonDerivative · entry 1

Snodgres Jon · CIK 0001613498 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,899

F1 · price: $52.7911 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.545 to $52.88, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 22, 2018 Filed Aug 24, 2018 20:16 UTC SaleCommon Stock 2,366 $51.44 $121,697.81
Disclosure

SEC source: 0000899243-18-023221 · doc4.xml · nonDerivative · entry 1

RYAN THOMAS F JR · CIK 0001263366 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,988

F1 · price: $51.4361 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.39 to $51.501, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 09, 2018 Filed Aug 13, 2018 20:06 UTC SaleCommon stock 39,215 $49.54 $1,942,691.49
Disclosure

SEC source: 0001250853-18-000113 · primary_doc.xml · nonDerivative · entry 2

EDDLEMAN ROY T · CIK 0001270264 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · As trustee

Disclosed balance after: 370,000

F3 · price: The price is a weighted-average price. The shares were sold in multiple transactions at prices ranging from $49.4328 to $49.5959, inclusive.

F4 · ownership.nature: The shares shown are held, of record, by a second charitable remainder unitrust of which the reporting person is the sole trustee and, as such, has investment and voting control over such shares, and is a lifetime beneficiary. The reporting person disclaims as beneficial ownership of the shares except to the extent of his pecuniary interest therein.

Read SEC document
August 09, 2018 Filed Aug 13, 2018 20:06 UTC SaleCommon stock 76,858 $49.67 $3,817,844.29
Disclosure

SEC source: 0001250853-18-000113 · primary_doc.xml · nonDerivative · entry 1

EDDLEMAN ROY T · CIK 0001270264 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · As trustee

Disclosed balance after: 720,000

F1 · price: The price is a weighted-average price. The shares were sold in multiple transactions at prices ranging from $49.6450 to $49.6950, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price with the price ranges set forth in this footnote and in footnote (3), below.

F2 · ownership.nature: The shares shown are held, of record, by a charitable remainder unitrust of which the reporting person is the sole trustee and, as such, has investment and voting control over such shares, and is a lifetime beneficiary. The reporting person disclaims as beneficial ownership of the shares except to the extent of his pecuniary interest therein.

Read SEC document
August 08, 2018 Filed Aug 8, 2018 22:10 UTC SaleCommon stock 4,770 $49.05 $233,970.41
Disclosure

SEC source: 0001250853-18-000112 · primary_doc.xml · nonDerivative · entry 3

EDDLEMAN ROY T · CIK 0001270264 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · As trustee

Disclosed balance after: 409,215

F4 · ownership.nature: The shares shown are held, of record, by a second charitable remainder unitrust of which the reporting person is the sole trustee and, as such, has investment and voting control over such shares, and is a lifetime beneficiary. The reporting person disclaims as beneficial ownership of the shares except to the extent of his pecuniary interest therein.

Read SEC document
August 07, 2018 Filed Aug 8, 2018 22:10 UTC SaleCommon stock 16,015 $49.05 $785,577.39
Disclosure

SEC source: 0001250853-18-000112 · primary_doc.xml · nonDerivative · entry 2

EDDLEMAN ROY T · CIK 0001270264 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 413,985

F3 · price: The price is a weighted-average price. The shares were sold in multiple transactions at prices ranging from $49.0500 to $49.0908, inclusive.

Read SEC document
August 06, 2018 Filed Aug 8, 2018 22:10 UTC SaleCommon stock 33,142 $49.05 $1,625,598.53
Disclosure

SEC source: 0001250853-18-000112 · primary_doc.xml · nonDerivative · entry 1

EDDLEMAN ROY T · CIK 0001270264 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · As trustee

Disclosed balance after: 796,858

F1 · price: The price is a weighted-average price. The shares were sold in multiple transactions at prices ranging from $49.207 to $49.1358, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price with the price ranges set forth in this footnote and in footnote (3), below.

F2 · ownership.nature: The shares shown are held, of record, by a charitable remainder unitrust of which the reporting person is the sole trustee and, as such, has investment and voting control over such shares, and is a lifetime beneficiary. The reporting person disclaims as beneficial ownership of the shares except to the extent of his pecuniary interest therein.

Read SEC document
July 26, 2018 Filed Jul 30, 2018 22:27 UTC PurchasePut option (right to sell) · Derivative 1 $837,500.00 Strike: $43.89 $837,500.00
Disclosure

SEC source: 0001250853-18-000107 · primary_doc.xml · derivative · entry 2

EDDLEMAN ROY T · CIK 0001270264 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · As trustee

Disclosed balance after: 1

Underlying: Common Stock · 250,000 shares

Expires 2019-07-26

F1 · security: The reporting person entered into a so-called zero-cost collar arrangement pursuant to which he wrote a covered call option and purchased a put option. Only one of the options can be "in the money" on the expiration date, at which time the in-the-money option will be exercised (or settled in cash), and the other option will expire. If neither option is in the money on the expiration date, both will expire.

F2 · ownership.nature: The securities shown are held of record by the Roy T. Eddleman Living Trust UAD 8-7-2000, of which the reporting person is the sole trustee and, as such, has investment and voting control over such securities.

Read SEC document
July 26, 2018 Filed Jul 30, 2018 22:27 UTC SaleCall option(obligation to sell) · Derivative 1 $837,500.00 Strike: $53.94 $837,500.00
Disclosure

SEC source: 0001250853-18-000107 · primary_doc.xml · derivative · entry 1

EDDLEMAN ROY T · CIK 0001270264 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · As trustee

Disclosed balance after: 1

Underlying: Common Stock · 250,000 shares

Expires 2019-07-26

F1 · security: The reporting person entered into a so-called zero-cost collar arrangement pursuant to which he wrote a covered call option and purchased a put option. Only one of the options can be "in the money" on the expiration date, at which time the in-the-money option will be exercised (or settled in cash), and the other option will expire. If neither option is in the money on the expiration date, both will expire.

F2 · ownership.nature: The securities shown are held of record by the Roy T. Eddleman Living Trust UAD 8-7-2000, of which the reporting person is the sole trustee and, as such, has investment and voting control over such securities.

Read SEC document
July 18, 2018 Filed Jul 20, 2018 12:04 UTC Tax withholdingCommon Stock 295 $47.91 $14,133.75
Disclosure

SEC source: 0001140361-18-032952 · doc1.xml · nonDerivative · entry 1

Snodgres Jon · CIK 0001613498 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,359

F1 · shares: Payment of tax liability made via forfeiture of 295 shares of Common Stock valued at a price of $47.911 per share on July 18, 2018.

Read SEC document
July 12, 2018 Filed Jul 16, 2018 21:06 UTC PurchasePut option (right to sell) · Derivative 1 $1,000,000.00 Strike: $43.50 $1,000,000.00
Disclosure

SEC source: 0001250853-18-000099 · primary_doc.xml · derivative · entry 2

EDDLEMAN ROY T · CIK 0001270264 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · As trustee

Disclosed balance after: 1

Underlying: Common Stock · 250,000 shares

Expires 2020-01-13

F1 · security: The reporting person entered into a so-called zero-cost collar arrangement pursuant to which he wrote a covered call option and purchased a put option. Only one of the options can be "in the money" on the expiration date, at which time the in-the-money option will be exercised (and settled in cash) and the other option will expire. If neither option is in the money on the expiration date, both will expire.

F2 · ownership.nature: The securities shown are held of record by the Roy T. Eddleman Living Trust UAD 8-7-2000, of which the reporting person is the sole trustee, and as such, has investment and voting control over such securities.

Read SEC document
July 12, 2018 Filed Jul 16, 2018 21:06 UTC SaleCall option (obligation to sell) · Derivative 1 $1,000,000.00 Strike: $54.93 $1,000,000.00
Disclosure

SEC source: 0001250853-18-000099 · primary_doc.xml · derivative · entry 1

EDDLEMAN ROY T · CIK 0001270264 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · As trustee

Disclosed balance after: 1

Underlying: Common Stock · 250,000 shares

Expires 2020-01-13

F1 · shares: The reporting person entered into a so-called zero-cost collar arrangement pursuant to which he wrote a covered call option and purchased a put option. Only one of the options can be "in the money" on the expiration date, at which time the in-the-money option will be exercised (and settled in cash) and the other option will expire. If neither option is in the money on the expiration date, both will expire.

F2 · ownership.nature: The securities shown are held of record by the Roy T. Eddleman Living Trust UAD 8-7-2000, of which the reporting person is the sole trustee, and as such, has investment and voting control over such securities.

Read SEC document
June 13, 2018 Filed Jun 21, 2018 16:44 UTC GiftCommon Stock 22,530 $0.00 $0.00
Disclosure

SEC source: 0001250853-18-000088 · primary_doc.xml · nonDerivative · entry 1

EDDLEMAN ROY T · CIK 0001270264 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · As trustee

Disclosed balance after: 2,903,446

F1 · ownership.nature: The shares shown are held of record by the Roy T. Eddleman Living Trust UAD 8-7-2000, of which the reporting person is the sole trustee, and as such, has investment and voting control over such shares.

Read SEC document
June 06, 2018 Filed Jun 7, 2018 20:28 UTC SaleCommon Stock 1,932 $44.31 $85,606.34
Disclosure

SEC source: 0001140361-18-027688 · doc1.xml · nonDerivative · entry 1

RYAN THOMAS F JR · CIK 0001263366 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,354

Read SEC document
May 21, 2018 Filed May 22, 2018 21:12 UTC
Hunt AnthonyDirector · Chief Executive Officer
SaleCommon Stock 16,249 $42.53 $691,016.35
Disclosure

SEC source: 0001140361-18-025220 · doc1.xml · nonDerivative · entry 1

Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 243,144

F1 · shares: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on November 17, 2017.

F2 · price: $42.5267 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.37 to $42.77, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 16, 2018 Filed May 17, 2018 20:45 UTC GrantStock Option (Right to Buy) · Derivative 3,304 $0.00 Strike: $42.07 $0.00
Disclosure

SEC source: 0001140361-18-024451 · doc1.xml · derivative · entry 3

RYAN THOMAS F JR · CIK 0001263366 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,304

Underlying: Common Stock · 3,304 shares

Expires 2028-05-16

F2 · derivative.exercise_date: Award vests in full one year from grant date on May 16, 2019.

Read SEC document
May 16, 2018 Filed May 17, 2018 20:45 UTC GrantCommon Stock 1,486 $0.00 $0.00
Disclosure

SEC source: 0001140361-18-024451 · doc1.xml · nonDerivative · entry 2

RYAN THOMAS F JR · CIK 0001263366 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,286

F1 · shares: Mr. Ryan was awarded 1,486 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The Restricted Stock Units vest on May 16, 2019. The Restricted Stock Units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

Read SEC document
May 16, 2018 Filed May 17, 2018 20:44 UTC
MUIR GLENN PDirector
GrantStock Option (Right to Buy) · Derivative 3,304 $0.00 Strike: $42.07 $0.00
Disclosure

SEC source: 0001140361-18-024450 · doc1.xml · derivative · entry 2

MUIR GLENN P · CIK 0001181190 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,304

Underlying: Common Stock · 3,304 shares

Expires 2028-05-16

F2 · derivative.exercise_date: Award vests in full one year from grant date on May 16, 2019.

Read SEC document
May 16, 2018 Filed May 17, 2018 20:44 UTC
MUIR GLENN PDirector
GrantCommon Stock 1,486 $0.00 $0.00
Disclosure

SEC source: 0001140361-18-024450 · doc1.xml · nonDerivative · entry 1

MUIR GLENN P · CIK 0001181190 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,455

F1 · shares: Mr. Muir was awarded 1,486 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The Restricted Stock Units vest on May 16, 2019. The Restricted Stock Units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

Read SEC document
May 16, 2018 Filed May 17, 2018 20:44 UTC GrantStock Option (Right to Buy) · Derivative 4,626 $0.00 Strike: $42.07 $0.00
Disclosure

SEC source: 0001140361-18-024449 · doc1.xml · derivative · entry 2

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,626

Underlying: Common Stock · 4,626 shares

Expires 2028-05-16

F2 · derivative.exercise_date: Award vests in full one year from grant date on May 16, 2019.

Read SEC document
May 16, 2018 Filed May 17, 2018 20:44 UTC GrantCommon Stock 2,080 $0.00 $0.00
Disclosure

SEC source: 0001140361-18-024449 · doc1.xml · nonDerivative · entry 1

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,037

F1 · shares: Ms. Dawes was awarded 2,080 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The Restricted Stock Units vest on May 16, 2019. The Restricted Stock Units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

Read SEC document
May 16, 2018 Filed May 17, 2018 20:43 UTC
Cox JohnDirector
GrantStock Option (Right to Buy) · Derivative 3,304 $0.00 Strike: $42.07 $0.00
Disclosure

SEC source: 0001140361-18-024448 · doc1.xml · derivative · entry 2

Cox John · CIK 0001498428 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,304

Underlying: Common Stock · 3,304 shares

Expires 2028-05-16

F2 · derivative.exercise_date: Award vests in full one year from grant date on May 16, 2019.

Read SEC document
May 16, 2018 Filed May 17, 2018 20:43 UTC
Cox JohnDirector
GrantCommon Stock 1,486 $0.00 $0.00
Disclosure

SEC source: 0001140361-18-024448 · doc1.xml · nonDerivative · entry 1

Cox John · CIK 0001498428 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,313

F1 · shares: Mr. Cox was awarded 1,486 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The Restricted Stock Units vest on May 16, 2019. The Restricted Stock Units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

Read SEC document
May 16, 2018 Filed May 17, 2018 20:43 UTC GrantStock Option (Right to Buy) · Derivative 3,304 $0.00 Strike: $42.07 $0.00
Disclosure

SEC source: 0001140361-18-024447 · doc1.xml · derivative · entry 2

COOPER GLENN L MD · CIK 0001046351 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,304

Underlying: Common Stock · 3,304 shares

Expires 2028-05-16

F2 · derivative.exercise_date: Award vests in full one year from grant date on May 16, 2019.

Read SEC document
May 16, 2018 Filed May 17, 2018 20:43 UTC GrantCommon Stock 1,486 $0.00 $0.00
Disclosure

SEC source: 0001140361-18-024447 · doc1.xml · nonDerivative · entry 1

COOPER GLENN L MD · CIK 0001046351 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,786

F1 · shares: Dr. Cooper was awarded 1,486 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The Restricted Stock Units vest on May 16, 2019. The Restricted Stock Units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.